Concepedia

Vernon T. Phan

VT

Statistics

Publications

13

Citations

1.4K

H-Index

12

Active since

2003

Affiliations

UCSF Helen Diller Family Comprehensive Cancer Center(Current)

University of Chicago

University of California, San Francisco

Howard Hughes Medical Institute

Principia Biopharma (United States)

Vernon T. Phan is an author at UCSF Helen Diller Family Comprehensive Cancer Center specializing in molecular oncology, medicine, and oncology.

Publications per year

2003–2017

13

Publications

13

Prolonged and tunable residence time using reversible covalent kinase inhibitors

J. Michael Bradshaw, Jesse M. McFarland, Ville O. Paavilainen et al. · Nature Chemical Biology · 2015 · 430 citations · Full text

, , +14

Cooperative Dynamics of AR and ER Activity in Breast Cancer

Nicholas C. D’Amato, Melita A. Gordon, Beatrice Babbs et al. · Molecular Cancer Research · 2016 · 156 citations · Full text

, , +17

Oncogenic RAS pathway activation promotes resistance to anti-VEGF therapy through G-CSF–induced neutrophil recruitment

Vernon T. Phan, Xiumin Wu, Jason Cheng et al. · Proceedings of the National Academy of Sciences · 2013 · 115 citations · Full text

, , +17

A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657

Jastinder Sohal, Vernon T. Phan, Philip V. Chan et al. · Blood · 2003 · 106 citations · Full text

, , +14

Expression of a functional VEGFR-1 in tumor cells is a major determinant of anti-PlGF antibodies efficacy

Jenny Yao, Xiumin Wu, Guanglei Zhuang et al. · Proceedings of the National Academy of Sciences · 2011 · 100 citations · Full text

, , +17

1–5 of 13